CD40LG and dengue disease: None of the 97 specimens from COVID-19 patients collected in Puerto Rico tested positive for anti-DENV IgM; 95 specimens tested negative and two returned equivocal results, indicating a 100% specificity during the period of symptomatic disease when most patients with dengue disease or Zika virus disease are usually tested (Table).